Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sunil Healthcare Ltd reported audited results for FY2026 ending March 31, 2026. Standalone revenue was Rs 2,183.73 Lakhs for Q4 and consolidated full-year revenue stood at Rs 8,475.02 Lakhs, showing marginal growth of ~1.6% YoY. The company posted a standalone net loss of Rs 602.41 Lakhs for the full year, a sharp decline from profit of Rs 2,014.89 Lakhs in FY2025. Consolidated PAT turned negative at Rs 121.57 Lakhs loss vs profit of Rs 4,136.34 Lakhs previously. Exceptional items of Rs 946.66 Lakhs were recorded (likely related to a loss event), partially offset by Rs 344.35 Lakhs insurance claim recognized. The Board did not recommend any dividend for FY2026. Auditors Singhi & Co. issued unmodified (clean) opinions on both standalone and consolidated financials. M/s Agrawal S. Lal & Co. was appointed as internal auditors for FY2027.
The company swung from profit to loss in FY2026, indicating significant operational challenges or one-time charges. Despite the loss, the clean audit opinion and insurance claim recovery provide some comfort. Shareholders face uncertainty with no dividend payout and deteriorating profitability.